Cabozantinib plus atezolizumab in non-clear cell kidney cancer
The results from an extended follow-up of the phase 1b [...]
Triple combination improves survival in patients with advanced kidney cancer
Results from the phase 3 COSMIC-313 trial showed that adding [...]
Quitting smoking reduces risk for kidney cancer progression
A recent study followed 212 smokers diagnosed with kidney cancer [...]
Brain metastases from kidney cancer treated with first-line therapies
A recent study looked at the outcomes of patients with [...]
Cancer Network Patient Journey Programme
This programme of 11 webinars involves a kidney cancer patient, [...]
Belzutifan plus cabozantinib combination shows promising results in kidney cancer
Kidney cancers often have mutations in a gene called the [...]
Stopping smoking after kidney cancer diagnosis may reduce the risk of cancer progression and death
A recent study looked at whether stopping smoking after a [...]
Adjuvant nivolumab plus ipilimumab for localised kidney cancer
In this randomised phase 3 trial, the effectiveness and safety [...]
Fat loss may result in worse outcomes for patients treated with immunotherapy for metastatic kidney cancer
A recent study presented at the Annual Congress of the [...]
Benefits persist for lenvatinib plus pembrolizumab in advanced kidney cancer
Lenvatinib plus pembrolizumab has already been shown to improve survival [...]
